Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments

SIMPLE SUMMARY: Biliary tract cancers (BTCs) are rare tumours associated with poor prognosis. In advanced-stage disease, two treatment lines are approved: gemcitabine-cisplatin in combination with checkpoint inhibitors, and 5-FU-oxaliplatin, with a median overall survival of approximately one year....

Descripción completa

Detalles Bibliográficos
Autores principales: Valery, Marine, Vasseur, Damien, Fachinetti, Francesco, Boilève, Alice, Smolenschi, Cristina, Tarabay, Anthony, Antoun, Leony, Perret, Audrey, Fuerea, Alina, Pudlarz, Thomas, Boige, Valérie, Hollebecque, Antoine, Ducreux, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526255/
https://www.ncbi.nlm.nih.gov/pubmed/37760415
http://dx.doi.org/10.3390/cancers15184446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526255/
https://www.ncbi.nlm.nih.gov/pubmed/37760415
http://dx.doi.org/10.3390/cancers15184446

Ejemplares similares